Go Back

Passionate About Eye Care and Biotech!

Reichert Technologies, a business of AMETEK, Inc., is a global leader in the design, engineering, development, and manufacture of eye care, analytical and life science instruments and medical devices. We specialize in diagnostic instruments and equipment for ophthalmologists, optometrists, opticians and retail eye centers. Reichert offers a line of laboratory and portable/field refractometers for customers in the automotive, food and beverage, chemical and industrial markets.

AMETEK Reichert

Healthcare

Reichert Brings Cutting-Edge Eye Care Tech to Vision Expo East 2025

MarketScale
March 25, 2025


 
As eye care rapidly evolves, Vision Expo East 2025 is the place to see where innovation meets clinical excellence — and Reichert is leading the charge. At booth F2201, practitioners can experience hands-on demos of Reichert’s latest breakthroughs in tonometry, digital refraction, and dry eye diagnostics. Of particular note is the new Tono-Vera® Tonometer, which simplifies intraocular pressure readings with its patented ActiView™ Positioning System. Reichert is also showcasing its premium Phoroptor® VRx Digital Refraction System alongside the intuitive SightChek® Digital Phoroptor, offering powerful options for practices of all sizes. With dry eye disease on the rise, their suite of evaluation and therapy devices helps practices meet growing demand. Visitors can also explore the Ocular Response Analyzer® G3, a game-changer in glaucoma management with its unique Corneal Hysteresis and IOPcc metrics. Plus, for those who stop by for a demo, there’s a chance to win a $1,000 Visa gift card — a rewarding way to explore the future of vision care.

Recent Episodes

healthcare
View episode

The Best Healthcare Platforms Are Built on Clear Communication, AI-Human Collaboration, and a Deep Understanding of the “Why”

Healthcare is being pushed to modernize faster than ever, as AI tools, virtual care, and digital patient experiences shift from innovation to expectation. Recent survey data from McKinsey & Company indicates that about half of U.S. healthcare leaders say their organizations have already put generative AI into practice, underscoring how quickly the technology is…

heart disease
View episode

Rethinking the Standard of Care: How Noninvasive Therapy Could Change Heart Disease Outcomes

Heart disease remains the leading cause of death in the U.S., with 683,491 deaths reported in 2024, according to the CDC. As cardiovascular care shifts toward access, prevention, and value-based outcomes, noninvasive therapies are gaining renewed attention for patients who continue to experience symptoms after traditional interventions. At the same time, rising healthcare costs…

leadership
View episode

Called to Lead: Joel Allison on Faith, Risk, and the Future of Healthcare Leadership

Healthcare leadership is being redefined in real time. With the rise of AI, mounting financial pressures, and workforce burnout, executives today are operating in an environment of continuous disruption and uncertainty. In fact, industry leaders now rank workforce shortages and digital transformation among their top concerns—forcing a new kind of leadership that blends decisiveness…

Launch Your Branded Show Today

Engage your audience with original, industry-specific content.

Book a Demo Talk to an Expert